Re-Establishment of the Advisory Group on Prevention, Health Promotion, and Integrative and Public Health, 10618-10619 [2013-03466]
Download as PDF
<![CDATA[
10618
Federal Register / Vol. 78, No. 31 / Thursday, February 14, 2013 / Notices
met in closed session to consider
matters related to the Corporation’s
supervision, corporate, and resolution
activities.
In calling the meeting, the Board
determined, on motion of Vice
Chairman Thomas M. Hoenig, seconded
by Director Jeremiah O. Norton
(Appointive), concurred in by Director
Thomas J. Curry (Comptroller of the
Currency), Director Richard Cordray
(Director, Consumer Financial
Protection Bureau), and Chairman
Martin J. Gruenberg, that Corporation
business required its consideration of
the matters which were to be the subject
of this meeting on less than seven days’
notice to the public; that no earlier
notice of the meeting was practicable;
that the public interest did not require
consideration of the matters in a
meeting open to public observation; and
that the matters could be considered in
a closed meeting by authority of
subsections (c)(4), (c)(6), (c)(8),
(c)(9)(A)(ii), (c)(9)(B), and (c)(10) of the
‘‘Government in the Sunshine Act’’ (5
U.S.C. 552b(c)(4), (c)(6), (c)(8),
(c)(9)(A)(ii), (c)(9)(B), and (c)(10)).
The meeting was held in the Board
Room of the FDIC Building located at
550—17th Street NW., Washington, DC.
Dated: February 12, 2013.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
[FR Doc. 2013–03579 Filed 2–12–13; 4:15 pm]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Re-Establishment of the Advisory
Group on Prevention, Health
Promotion, and Integrative and Public
Health
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The U.S. Department of
Health and Human Services announces
re-establishment of the Advisory Group
on Prevention, Health Promotion, and
Integrative and Public Health (hereafter
referred to as ‘‘the Advisory Group’’).
Authorization to re-establish the
Advisory Group is given under
Executive Order 13631, dated December
7, 2012.
FOR FURTHER INFORMATION CONTACT:
Corinne Graffunder, Designated Federal
Officer (DFO) of the Advisory Group,
Office of the Associate Director for
sroberts on DSK5SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:16 Feb 13, 2013
Jkt 229001
Policy; Centers for Disease Control and
Prevention; 1600 Clifton Road NE., MS
D–28; Atlanta, GA 30329; Telephone:
(404) 639–7514; and/or the following
person may be contacted: Olga Nelson,
Committee Management Officer, Office
of the Assistant Secretary for Health;
Department of Health and Human
Services; 200 Independence Avenue
SW., Room 714B; Washington, DC
20201; Telephone: (202) 690–5205; Fax:
(202) 401–2222.
SUPPLEMENTARY INFORMATION: It was
mandated under the Patient Protection
and Affordable Care Act that the
President establish the Advisory Group.
The President complied with the statute
under Executive Order 13544, dated
June 10, 2010. The Advisory Group was
established as a non-discretionary
federal advisory committee. Functioning
as a federal advisory committee, the
Advisory Group is governed by
provisions of the Federal Advisory
Committee Act (FACA). FACA
stipulates that appropriate action must
be taken to renew the charter for a
federal advisory committee every two
years in order for the committee to
continue to operate. Under Executive
Order 13544, authorization was given
for the Advisory Group to operate for
two years, from June 10, 2010 to June
10, 2012. Since the Advisory Group was
established by Presidential directive, it
was necessary for appropriate action to
be taken by the President or agency
head to give authorization for the
Advisory Group to be continued. A
subsequent directive was issued,
Executive Order 13591, dated November
23, 2011, to give authorization for the
Advisory Group to continue to operate
until September 30, 2012. No action was
taken to continue the Advisory Group
after the designated termination date.
Therefore, the Advisory Group was
terminated on September 30, 2012.
On December 7, 2012, Executive
Order 13631 was issued. This directive
gives authorization for the Advisory
Group to be re-established. A charter
was developed to re-establish the
Advisory Group. The charter was
approved by the Secretary of Health and
Human Services and filed with the
appropriate Congressional committees,
the Library of Congress, and the
Committee Management Secretariat
under the General Services
Administration (GSA) on February 6,
2013.
Objectives and Scope of Activities.
The Advisory Group provides
recommendations and advice to the
National Prevention, Health Promotion,
and Public Health Council (hereafter
referred to as the ‘‘Council’’). The
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Advisory Group provides assistance to
the Council in carrying out its mission.
The Advisory Group develops policy
and program recommendations and
advises the Council on lifestyle-based
chronic disease prevention and
management, integrative health care
practices, and health promotion.
Membership and Designation. The
Advisory Group is authorized to
consists of not more than 25 non-federal
members, who are appointed by the
President. In appointing members, the
President is to ensure that the Advisory
Group includes a diverse group of
licensed health professionals, including
integrative health practitioners who
have expertise in (1) Worksite health
promotion; (2) community services,
including community health centers; (3)
preventive medicine; (4) health
coaching; (5) public health education;
(6) geriatrics; and (7) rehabilitation
medicine.
The Advisory Group had 22 members
when it was terminated on September
30, 2012. It is stipulated under
Executive Order 13631 that the same
members who were serving on the
Advisory Group when it was terminated
shall be reappointed as if the Advisory
Group had continued without
termination. Members of the Advisory
Group are classified as special
Government employees (SGEs).
Administrative Management and
Support. HHS provides funding and
administrative support for the Advisory
Group to the extent permitted by law
within existing appropriations. Staff
within Office of the Assistant Secretary
for Health (OASH) provide management
and oversight for support services
provided to the Advisory Group. OASH
is a staff division within the Office of
the Secretary, HHS.
The Advisory Group reports to the
Surgeon General, U.S. Public Health
Service. The Office of the Surgeon
General is a program office that is
organizationally located within OASH.
A copy of the charter and information
on activities and accomplishments of
the Advisory Group can be obtained
from the designated contacts or by
accessing the FACA database that is
maintained by the GSA Committee
Management Secretariat. The Web site
for the FACA database is https://fido.gov/
facadatabase/.
Authority: Authority to establish the
Advisory Group was given under Executive
Order 13544, dated June 10, 2010, in
accordance with Section 4001 of the Patient
Protection and Affordable Care Act, Public
Law 111–148, dated March 23, 2010. The
Advisory Group was terminated on
September 30, 2012, by Executive Order
13591, dated November 23, 2011. Authority
E:\FR\FM\14FEN1.SGM
14FEN1
10619
Federal Register / Vol. 78, No. 31 / Thursday, February 14, 2013 / Notices
for the Advisory Group to be re-established
is given under Executive Order 13631, dated
December 7, 2012. The Advisory Group is
governed by provisions of the Federal
Advisory Committee Act (FACA), Public Law
92–463, as amended (5 U.S.C. App.), which
sets forth standards for the formation and use
of advisory committees.
Dated: February 8, 2013.
Wanda K. Jones,
Principal Deputy Assistant Secretary for
Health.
[FR Doc. 2013–03466 Filed 2–13–13; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
[Document Identifier HHS–OS–18521–60D]
Agency Information Collection
Activities; Proposed Collection; Public
Comment Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, announces plans
to submit a new Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting that ICR to
OMB, OS seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on the ICR must be
received on or before April 15, 2013.
ADDRESSES: Submit your comments to
Information.CollectionClearance@
hhs.gov or by calling (202) 690–6162.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Information Collection Clearance staff,
Information.CollectionClearance@hhs.
gov or (202) 690–6162.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
document identifier HHS–OS–18521–
60D for reference.
Information Collection Request Title:
Evaluation of Implementation of the
Viral Hepatitis Action Plan.
Abstract: In response to the viral
hepatitis epidemic in the United States,
the Department of Health and Human
Services (HHS) released the Action Plan
for the Prevention, Care, and Treatment
of Viral Hepatitis (Action Plan) in May
2011 to provide a comprehensive
strategic plan to address viral hepatitis
B and C. Implementation of the Action
Plan requires actions across a variety of
agencies including national, state/local
government, community-based
organizations, and the private sector.
The Evaluation of Implementation of the
Viral Hepatitis Action Plan will assess
state and local response to activities that
support the Action Plan, identify
barriers to implementation and
strategies to address these barriers, and
inform future viral hepatitis efforts.
Need and Proposed Use of the
Information: The purpose of this project
is to evaluate the state and local
response to and implementation of the
Action Plan and examine viral hepatitis
activities that are occurring in the four
jurisdictions that have been pre-selected
for the evaluation: Alabama,
Massachusetts, New York, and
Washington State. The information
collected through the evaluation will
position OASH to better understand
implementation of the Action Plan at
the state and local levels and barriers
that might be occurring in the selected
jurisdictions. The evaluation will also
serve to examine the landscape of viral
hepatitis activities that are taking place
in the selected jurisdictions. The results
of the evaluation will enable OASH to
understand and identify potential
strategies to strengthen local
implementation of the Action Plan,
address barriers, and inform future
implementation efforts.
Likely Respondents: State Viral
Hepatitis Prevention Coordinators (CDCfunded state health department staff);
other state and local health department
stakeholders such as HIV and
Immunization Program staff; national
organization representatives who are
involved in viral hepatitis program
development and advocacy; local viral
hepatitis stakeholders including health
care and substance abuse treatment
providers, non-profit community-based
organization staff and volunteers, and
others identified by the State Viral
Hepatitis Prevention Coordinator (see
above).
Burden Statement: The estimated
burden for data collection involves
scheduling and conducting key
informant interviews among a variety of
stakeholder groups including the CDCfunded Adult Viral Hepatitis Prevention
Coordinators, state and local health
departments, community-based
organizations, correctional facilities,
and healthcare providers. These
interviews will be conducted in four
states (Alabama, Massachusetts, New
York, and Washington). Up to twelve
additional interviews will also be
conducted with select national-level
stakeholders. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
4
16
12
12
12
12
1
1
1
1
1
1
1.5
45/60
30/60
30/60
30/60
30/60
6
12
6
6
6
6
Total ..........................................................................................................
sroberts on DSK5SPTVN1PROD with NOTICES
Adult Viral Hepatitis Prevention Coordinators .................................................
State and local health departments .................................................................
Community-based organizations .....................................................................
National organizations .....................................................................................
Correctional facilities ........................................................................................
Healthcare providers ........................................................................................
........................
........................
........................
42
VerDate Mar<15>2010
17:16 Feb 13, 2013
Jkt 229001
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
E:\FR\FM\14FEN1.SGM
14FEN1
]]>Agencies
[Federal Register Volume 78, Number 31 (Thursday, February 14, 2013)]
[Notices]
[Pages 10618-10619]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03466]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Re-Establishment of the Advisory Group on Prevention, Health
Promotion, and Integrative and Public Health
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The U.S. Department of Health and Human Services announces re-
establishment of the Advisory Group on Prevention, Health Promotion,
and Integrative and Public Health (hereafter referred to as ``the
Advisory Group''). Authorization to re-establish the Advisory Group is
given under Executive Order 13631, dated December 7, 2012.
FOR FURTHER INFORMATION CONTACT: Corinne Graffunder, Designated Federal
Officer (DFO) of the Advisory Group, Office of the Associate Director
for Policy; Centers for Disease Control and Prevention; 1600 Clifton
Road NE., MS D-28; Atlanta, GA 30329; Telephone: (404) 639-7514; and/or
the following person may be contacted: Olga Nelson, Committee
Management Officer, Office of the Assistant Secretary for Health;
Department of Health and Human Services; 200 Independence Avenue SW.,
Room 714B; Washington, DC 20201; Telephone: (202) 690-5205; Fax: (202)
401-2222.
SUPPLEMENTARY INFORMATION: It was mandated under the Patient Protection
and Affordable Care Act that the President establish the Advisory
Group. The President complied with the statute under Executive Order
13544, dated June 10, 2010. The Advisory Group was established as a
non-discretionary federal advisory committee. Functioning as a federal
advisory committee, the Advisory Group is governed by provisions of the
Federal Advisory Committee Act (FACA). FACA stipulates that appropriate
action must be taken to renew the charter for a federal advisory
committee every two years in order for the committee to continue to
operate. Under Executive Order 13544, authorization was given for the
Advisory Group to operate for two years, from June 10, 2010 to June 10,
2012. Since the Advisory Group was established by Presidential
directive, it was necessary for appropriate action to be taken by the
President or agency head to give authorization for the Advisory Group
to be continued. A subsequent directive was issued, Executive Order
13591, dated November 23, 2011, to give authorization for the Advisory
Group to continue to operate until September 30, 2012. No action was
taken to continue the Advisory Group after the designated termination
date. Therefore, the Advisory Group was terminated on September 30,
2012.
On December 7, 2012, Executive Order 13631 was issued. This
directive gives authorization for the Advisory Group to be re-
established. A charter was developed to re-establish the Advisory
Group. The charter was approved by the Secretary of Health and Human
Services and filed with the appropriate Congressional committees, the
Library of Congress, and the Committee Management Secretariat under the
General Services Administration (GSA) on February 6, 2013.
Objectives and Scope of Activities. The Advisory Group provides
recommendations and advice to the National Prevention, Health
Promotion, and Public Health Council (hereafter referred to as the
``Council''). The Advisory Group provides assistance to the Council in
carrying out its mission. The Advisory Group develops policy and
program recommendations and advises the Council on lifestyle-based
chronic disease prevention and management, integrative health care
practices, and health promotion.
Membership and Designation. The Advisory Group is authorized to
consists of not more than 25 non-federal members, who are appointed by
the President. In appointing members, the President is to ensure that
the Advisory Group includes a diverse group of licensed health
professionals, including integrative health practitioners who have
expertise in (1) Worksite health promotion; (2) community services,
including community health centers; (3) preventive medicine; (4) health
coaching; (5) public health education; (6) geriatrics; and (7)
rehabilitation medicine.
The Advisory Group had 22 members when it was terminated on
September 30, 2012. It is stipulated under Executive Order 13631 that
the same members who were serving on the Advisory Group when it was
terminated shall be reappointed as if the Advisory Group had continued
without termination. Members of the Advisory Group are classified as
special Government employees (SGEs).
Administrative Management and Support. HHS provides funding and
administrative support for the Advisory Group to the extent permitted
by law within existing appropriations. Staff within Office of the
Assistant Secretary for Health (OASH) provide management and oversight
for support services provided to the Advisory Group. OASH is a staff
division within the Office of the Secretary, HHS.
The Advisory Group reports to the Surgeon General, U.S. Public
Health Service. The Office of the Surgeon General is a program office
that is organizationally located within OASH.
A copy of the charter and information on activities and
accomplishments of the Advisory Group can be obtained from the
designated contacts or by accessing the FACA database that is
maintained by the GSA Committee Management Secretariat. The Web site
for the FACA database is https://fido.gov/facadatabase/.
Authority: Authority to establish the Advisory Group was given
under Executive Order 13544, dated June 10, 2010, in accordance with
Section 4001 of the Patient Protection and Affordable Care Act,
Public Law 111-148, dated March 23, 2010. The Advisory Group was
terminated on September 30, 2012, by Executive Order 13591, dated
November 23, 2011. Authority
[[Page 10619]]
for the Advisory Group to be re-established is given under Executive
Order 13631, dated December 7, 2012. The Advisory Group is governed
by provisions of the Federal Advisory Committee Act (FACA), Public
Law 92-463, as amended (5 U.S.C. App.), which sets forth standards
for the formation and use of advisory committees.
Dated: February 8, 2013.
Wanda K. Jones,
Principal Deputy Assistant Secretary for Health.
[FR Doc. 2013-03466 Filed 2-13-13; 8:45 am]
BILLING CODE 4150-28-P
